Eaton ETN Slides 212 as Selling Pressure Mounts 20260515 Russias Oil Exports Hold Steady Despite Fresh US Sanctions Goldman Sachs Reports Winklevoss Twins Inject 100 Million into Gemini Stock Surges in Premarket Teslas 250 Million Germany Bet Spending Heavily on Battery Cell Production Is Cadiz CDZIP Still a Buy After 159 Rally 20260515 Marc Jacobs Label Departs LVMH After Nearly 30 Years Designer Stays as Creative Director Should You Sell Pagaya PGYWW After 714 Drop 20260519 Telecom TEO Delivers Q1 2026 Beat EPS 144378 vs 1268 Expected SpaceX IPO Nvidia Earnings and Bezos on AI Bubble Highlight Morning Market Updates Japans Exports Extend EightMonth Growth Streak Amid Ongoing Supply Chain Challenges Goldman Sachs Exits Apple Card Partnership Stock Enters Potential Buy Zone CD Rates Reach 4 APY as of May 27 2026 What Savers Need to Know Amid Scam Crackdown Crypto Giants Continue Fueling Bitcoin ATM Growth Quantum Computing Stocks Surge as US Unveils 2 Billion Funding Plan for Nine Firms CE Q1 2026 Earnings EPS Misses Estimates by 46 Stock Gains 107 SYF Q1 2026 Earnings EPS Beats Estimates Stock Edges Lower ES Q1 2026 Earnings EPS Falls Short of Estimates Despite Positive Stock Movement CRISPR Therapeutics Q1 2026 Earnings Slight EPS Miss as Clinical Pipeline Progresses KSPI Q4 2025 Earnings EPS Misses Estimates Modestly Shares Edge Higher GEF Q1 2026 Earnings EPS Beats Estimates Modestly Amid Missing Revenue Details MongoDB Stock Slides 42 Key Levels to Watch as Support Approaches Brookfield Asset Management BAM Holds Steady Near 49 Modest Gains Amid Consolidation Federal Signal Corporation FSS Slides 269 Testing Key Support Amid Sector Headwinds SelectQuote SLQT Drops 566 to 100 Approaching Critical Support Vertex Inc VERX Rallies 2 as Stock Approaches Key Resistance Zone Five Below Slips 23 Support Levels in Focus as Retail Sector Weakens Gold Prices Decline as Fed Governor Waller Signals Potential Rate Hike Amid Iran War Energy Shock TJX Q1 2026 Earnings EPS Beats Estimates by Nearly 16 Stock Edges Higher Inhibikase Therapeutics IKT Recovers 35 as Buyers Defend Key Support Level